Flintridge, CA, United States of America

Wijbe M Kast




Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wijbe M Kast: Innovator in Cancer Treatment

Introduction

Wijbe M Kast is a notable inventor based in Flintridge, CA (US). He has made significant contributions to the field of cancer treatment through his innovative use of liposomes. With a total of 2 patents, his work focuses on enhancing the delivery of therapeutic agents to combat cancer effectively.

Latest Patents

Kast's latest patents include the use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment. This invention involves compositions that utilize a continuous hydrophobic phase and liposomes to deliver an antigen capable of inducing a cytotoxic T lymphocyte (CTL) response. The methods developed for this treatment aim to improve the efficacy of cancer therapies.

Career Highlights

Kast is associated with Immunovaccine Technologies Inc., where he applies his expertise in developing innovative cancer treatment solutions. His work has been instrumental in advancing the understanding and application of liposomal technology in medical treatments.

Collaborations

Kast has collaborated with notable colleagues such as Pirouz M Daftarian and Marc Mansour, contributing to a dynamic research environment focused on cancer therapies.

Conclusion

Wijbe M Kast's contributions to cancer treatment through his innovative patents highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in therapeutic delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…